Animal Health & Welfare (PHAW)*
Partnership website: https://www.pahealthwellness.com/
The partnership aims to deliver key knowledge, services and products to significantly improve the control of animal infectious diseases and animal welfare in a coordinated way which will sustain animal production and protect public health. It will involve reference laboratories, funding agencies and cooperate with the private sector.
By 2030, programmes will be further aligned, the animal health and welfare research and innovation ecosystem will be stronger, improving preparedness and providing additional solutions to prevent, detect and respond to priority infectious animal diseases, fight antimicrobial resistance, and improve animal welfare.
Final partnership proposal (April 2022)
Contact
Commission services: Jean-Charles Cavitte, Valerio Abbadessa
Partners: Sciensano, the Belgian Institute for Health - Hein Imberechts, Diagnostics For Animals - Jean-Louis Hunault
* Calls with opening dates in 2023-2024
What are partnerships?
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
How to use partnerships?
-
orientation
Partnerships publish strategic documents, e.g. outlining the main research and innovation challenges or key focus points. -
networking
Partnerships often organise events, such as info days, brokerage events, etc. Meet potential partners and learn about the nuances that are not visible in the official documents. -
ecosystem analysis
Partnerships typically have an advisory board, and publish impact studies of previous actions. These are good sources of information to uncover the main R&D&I players in the domain. -
steering the agenda
Partnerships collaborate with the EC on outlining the strategy and the future funding opportunities in their domain, based on input from industry, academia, and other stakeholders.
Testimonial
BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
